March 31 (Reuters) - Opthea Ltd OPT.AX:
ANNOUNCES DECISION TO DISCONTINUE WET AMD TRIALS
CONTINUES ACTIVE DISCUSSIONS WITH DFA INVESTORS
ESTIMATES WILL HAVE UNAUDITED CASH AND CASH EQUIVALENTS OF US$100M AT END OF MARCH 2025
THERE REMAINS MATERIAL UNCERTAINTY AS TO OPTHEA'S ABILITY TO CONTINUE AS A GOING CONCERN
Further company coverage: OPT.AX
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.